Evidence map›Paper›PMID 40883025›Full record

SynthesisCancer genomics & proteomics

Association of

Charoula Achilla, Lefteris Angelis, Theodosios Papavramidis, Angeliki Chorti, Anthoula Chatzikyriakidou

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Cancer genomics & proteomics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Charoula AchillaLaboratory of Medical Biology - Genetics, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Lefteris AngelisSchool of Informatics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Theodosios PapavramidisFirst Propedeutic Department of Surgery, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Angeliki ChortiFirst Propedeutic Department of Surgery, AHEPA University Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Anthoula ChatzikyriakidouLaboratory of Medical Biology - Genetics, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece; chatzikyra@auth.gr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimCancer development involves complex interactions between immune mechanisms and the tumor microenvironment, with regulatory T cells (Tregs) being implicated in suppressing anti-tumor immunity. The X-linked gene Forkhead Box P3 ( MATERIALS AND

methodsA systematic search of PubMed, Google Scholar, and Scopus identified seventeen eligible case-control studies, including 6719 cancer patients and 6879 healthy controls. The statistical analyses employed an X-linked Generalized Linear Regression Model (GLRM) and a sex-stratified meta-analysis calculating odds ratios with 95% confidence intervals.

resultsThe results indicated that the presence of the A allele increases cancer risk in White and Asian populations. Furthermore, the A allele and the AA genotype were associated with breast cancer in Asians, while the AC genotype appeared protective against acute lymphoblastic leukemia in Whites possibly through non-random X-chromosome inactivation. The GLRM proved more robust, identifying additional associations and accounting for risk factors.

conclusionThe present study suggests a new statistical approach for analyzing X-linked genotypic data. Additionally, it underscores that the

Indexed as

Chromosomes, Human, XForkhead Transcription FactorsNeoplasmsPolymorphism, Single NucleotideFemaleGenetic Predisposition to DiseaseGenotypeHumansMaleForkhead Transcription FactorsFOXP3 protein, humancancerFOXP3genetic variantmeta-analysisreviewrs3761548X-chromosome

Identifiers

PMID40883025
PMCPMC12402714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.